drugset / Trial / NCT01952288

Simvastatin for mTBI

NCT01952288

Phase 4 Completed 5 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Study of simvastatin in Iraq/Afghanistan Veterans with multiple blast exposure and mTBI. The study will measure substances in cerebrospinal fluid (CSF) that are related to dementing disorders.

Timeline

Start
2013-09-16
Primary completion
2017-06-20
Completion
2017-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg